ECG changes during haloperidol and pimozide treatment of Tourette's disorder
- 1 May 1987
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 144 (5) , 673-675
- https://doi.org/10.1176/ajp.144.5.673
Abstract
The ECG QTc interval was significantly prolonged by pimozide but not haloperidol or placebo in a randomized clinical trial with 40 patients with Tourette's disorder. However, no adverse cardiac effects or differences in rate, rhythm, or waveform were found.This publication has 2 references indexed in Scilit:
- Controlled Study of Pimozide vs. Placebo in Tourette's SyndromeJournal of the American Academy of Child Psychiatry, 1984
- Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists.Proceedings of the National Academy of Sciences, 1983